Novacyt sells 'NOVAprep' business to Algimed Trade
27th Dec 2019 15:36
(Sharecast News) - Clinical diagnostics specialist Novacyt has completed the sale of 'NOVAprep' assets to Algimed Trade, it announced on Friday, for a total consideration of €0.4m and a 10% royalty on sales in certain defined territories.
Read moreNovacyt announces new molecular diagnostic multiplex test
7th Oct 2019 15:35
(Sharecast News) - Clinical diagnostics specialist Novacyt announced the successful development of a new molecular diagnostic multiplex test for respiratory infections on Monday, which it said was ready for launch in North America in time for the United States cold and flu season.
Read moreNovacyt trading in line as it seeks fresh funding
26th Feb 2019 15:47
(Sharecast News) - Clinical diagnostics specialist Novacyt updated the market on its current position and funding plans on Tuesday, confirming that 2019 trading had started positively and was in line with 2019 management expectations.
Read moreNovacyt launches two new CE-marked molecular products
21st Dec 2018 14:31
(Sharecast News) - Clinical diagnostics specialist Novacyt announced the launch of new CE-marked approved molecular products, the 'genesig' Real-Time PCR BK virus (BKV) kit and the 'genesig' Real-Time PCR Epstein-Barr Virus (EBV) kit.
Read moreNovacyt stumbles as Novaprep business tanks
2nd Aug 2018 11:58
(Sharecast News) - Novacyt on Thursday confirmed that it will carry out a strategic review after reporting that full-year group revenue will be lower than previously expected due to losses in its Novaprep business.
Read more